Viewing Study NCT05998993


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-05-13 @ 6:40 PM
Study NCT ID: NCT05998993
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-21
First Post: 2023-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)
Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None EGF-R Positive Non-Small Cell Lung Cancer View
None Non Small Cell Lung Cancer View
None EGFR Exon 19 Deletion View
None EGFR Exon 21 Mutation View
None EGFR G719X View
Keywords: